CytomX Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business Update


You May Also Like

Genmab Announces Data to be Presented at 2018 ASH Annual Meeting

Media Release Thirty-five total abstracts on Genmab owned and partnered programs scheduled for presentation ...

Kura Oncology to Present at Deutsche Bank 43rd Annual Health Care Conference

SAN DIEGO, May 03, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage ...